Volume 68, Issue 9 (6 2010)                   Tehran Univ Med J 2010, 68(9): 497-507 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

B L, A A. Recombinant parathormone and osteoporosis: a review article. Tehran Univ Med J. 2010; 68 (9) :497-507
URL: http://tumj.tums.ac.ir/article-1-309-en.html
1- , emrc@tums.ac.ir
Abstract:   (3484 Views)
Osteoporosis is a condition characterized with reduced bone density and destruction of the bone structure. The ideal treatment aims to reduce the risk of fracture while improving the density and structure of the bone. Parathormone (PTH) and its main analogue triparatide (rhPTH [1-34]) is a new class of anabolic medications which accelerates the healing process in the fractured bone through improving bone formation and therefore is used for treating severe osteoporosis. The present review article was designed to report the history, different types, anabolic and catabolic effects, complications, indications and contraindications of the hormone.
Full-Text [PDF 320 kb]   (1186 Downloads)    

Add your comments about this article : Your username or Email:
CAPTCHA code

Send email to the article author


© 2018 All Rights Reserved | Tehran University Medical Journal TUMS Publications

Designed & Developed by : Yektaweb